SCYNEXIS, Inc. Increase (Decrease) in Accounts Receivable
SCYNEXIS, Inc. (SCYX) reported Increase (Decrease) in Accounts Receivable of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2025-03-12
- SCYNEXIS, Inc. increase (decrease) in accounts receivable for the quarter ending 2024-12-31 was $0.00.
- SCYNEXIS, Inc. increase (decrease) in accounts receivable for the quarter ending 2024-09-30 was $0.00.
- SCYNEXIS, Inc. increase (decrease) in accounts receivable for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- SCYNEXIS, Inc. increase (decrease) in accounts receivable for the quarter ending 2024-03-31 was $0.00.
- SCYNEXIS, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $0.00.
- SCYNEXIS, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$2.10M, a 269.44% decline from fiscal 2022.
- SCYNEXIS, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $1.24M, a 44.02% increase from fiscal 2021.
- SCYNEXIS, Inc. increase (decrease) in accounts receivable for fiscal 2021 was $861.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $0.00 derived: sum of 2 quarters · filed 2025-03-12 | $0.00 derived: sum of 3 quarters · filed 2025-03-12 | $0.00 10-K · filed 2025-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | -$2.25M derived: sum of 4 quarters · filed 2025-03-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$2.25M derived: sum of 3 quarters · filed 2025-03-12 | -$2.34M derived: sum of 4 quarters · filed 2025-03-12 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | -$2.25M derived: sum of 2 quarters · filed 2025-03-12 | -$2.34M derived: sum of 3 quarters · filed 2025-03-12 | -$2.06M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$2.34M derived: sum of 2 quarters · filed 2025-03-12 | -$2.06M derived: sum of 3 quarters · filed 2025-03-12 | -$2.10M 10-K · filed 2025-03-12 |
| 2023-09-30 | -$99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $185.00K derived: sum of 2 quarters · filed 2024-11-06 | $144.00K 10-Q · filed 2024-11-06 | -$248.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $284.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $243.00K 10-Q · filed 2024-08-08 | -$149.00K derived: sum of 3 quarters · filed 2024-08-08 | $133.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$41.00K 10-Q · filed 2024-05-08 | -$433.00K derived: sum of 2 quarters · filed 2024-05-08 | -$151.00K derived: sum of 3 quarters · filed 2024-05-08 | |
| 2022-12-31 | -$392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$110.00K derived: sum of 2 quarters · filed 2024-03-28 | $1.24M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.63M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $1.35M 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $861.00K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 derived: sum of 3 quarters · filed 2017-03-13 | $0.00 10-K · filed 2017-03-13 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | -$554.00K derived: sum of 4 quarters · filed 2017-03-13 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | -$554.00K derived: sum of 3 quarters · filed 2017-03-13 | -$245.00K derived: sum of 4 quarters · filed 2017-03-13 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | -$554.00K derived: sum of 2 quarters · filed 2017-03-13 | -$245.00K derived: sum of 3 quarters · filed 2017-03-13 | $417.00K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-12-31 | -$554.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$245.00K derived: sum of 2 quarters · filed 2017-03-13 | $417.00K derived: sum of 3 quarters · filed 2017-03-13 | -$31.00K 10-K · filed 2017-03-13 |
| 2015-09-30 | $309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $971.00K derived: sum of 2 quarters · filed 2016-11-07 | $523.00K 10-Q · filed 2016-11-07 | $710.00K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $662.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $214.00K 10-Q · filed 2016-08-08 | $401.00K derived: sum of 3 quarters · filed 2017-03-13 | $259.00K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | -$448.00K 10-Q · filed 2016-05-09 | -$261.00K derived: sum of 2 quarters · filed 2017-03-13 | -$403.00K derived: sum of 3 quarters · filed 2017-03-13 | -$284.00K derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $45.00K derived: sum of 2 quarters · filed 2017-03-13 | $164.00K derived: sum of 3 quarters · filed 2017-03-13 | $439.00K 10-K · filed 2017-03-13 |
| 2014-09-30 | -$142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$23.00K derived: sum of 2 quarters · filed 2015-11-13 | $252.00K 10-Q · filed 2015-11-13 | -$777.00K derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | $119.00K derived: 10-Q 6 month − 8-K 3 month · filed 2015-08-19 | $394.00K 10-Q · filed 2015-08-19 | -$635.00K derived: sum of 3 quarters · filed 2015-10-30 | -$791.00K derived: sum of 4 quarters · filed 2015-10-30 |
| 2014-03-31 | $275.00K 8-K · filed 2015-10-30 | -$754.00K derived: sum of 2 quarters · filed 2015-10-30 | -$910.00K derived: sum of 3 quarters · filed 2015-10-30 | -$1.32M derived: sum of 4 quarters · filed 2015-10-30 |
| 2013-12-31 | -$1.03M derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | -$1.19M derived: sum of 2 quarters · filed 2015-10-30 | -$1.60M derived: sum of 3 quarters · filed 2015-10-30 | -$1.37M 8-K · filed 2015-10-30 |
| 2013-09-30 | -$156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$570.00K derived: sum of 2 quarters · filed 2014-11-13 | -$337.00K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | -$414.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-13 | -$181.00K 10-Q · filed 2014-08-13 | ||
| 2013-03-31 | $233.00K 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |